A bankruptcy court judge has approved the settlement of thousands of lawsuits against Purdue Pharma, maker of the powerful prescription painkiller OxyContin.

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic.

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller.

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one.

The Supreme Court has rejected a settlement for OxyContin maker Purdue Pharma and members of the Sackler family who own the company.

The Sackler family members who own OxyContin maker Purdue Pharma say they're disappointed in the Supreme Court's rejection of a nationwide settlement that would've shielded them from civil lawsuits over the toll of opioids but also would've provided billions of dollars to combat the epidemic.

The legality of an agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids is going before the Supreme Court.

OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family who own the company to avoid civil lawsuits over the opioid crisis, a court has ruled.

A woman who lost two sons to overdoses says she hopes a federal court clears the way for a settlement of lawsuits against OxyContin maker Purdue Pharma.

The British Museum will remove the Sackler name from galleries, rooms and endowments following global outrage over the role the family played in the opioid crisis.

Yale University has begun removing the Sackler name from its campus several years after announcing it would no longer accept donations from the family that owns OxyContin maker Purdue Pharma.

A sense of closure is mixing with anger and pain for some of the nearly two dozen people who told their personal stories to members of the family that owns OxyContin maker Purdue Pharma.

Addiction and overdose survivors and those who have lost loved ones have unleashed their emotions on members of the family they blame for fueling the opioid epidemic.

A judge has indicated he is moving forward with a plan for the owners of OxyContin maker Purdue Pharma to pump at least another $1.2 billion into a nationwide settlement of lawsuits against over the toll of opioids.

Some relatives of those who died in the opioid crisis will receive payments from a settlement with the maker of OxyContin that aren't even enough to reimburse for the cost of a funeral.

A report filed in federal bankruptcy court says members of the Sackler family who own Purdue Pharma are willing to increase their contribution to a nationwide opioid settlement by more than $1 billion.

A judge has kept lawsuits against OxyContin maker Purdue Pharma and members of the Sackler family who own it on hold until Feb. 1 but ordered the parties to negotiate a new settlement.

The end of the Purdue Pharma bankruptcy case has left a bitter taste for those who wanted to see more accountability for members of the Sackler family.

A landmark settlement in the nation’s opioid epidemic is forcing the owners of OxyContin maker Purdue Pharma to give up the company and pay out $4.5 billion.

A federal bankruptcy judge has approved with conditions a historic opioid settlement between Purdue Pharma and thousands of local and state governments.

Purdue Pharma's quest to settle thousands of lawsuits over OxyContin's toll has entered its final phase with the grudging acceptance of most of those who have claims against the company.

OxyContin maker Purdue Pharma's plan to reorganize into an entity whose profits will be used to combat the U.S. opioid crisis got a big boost as 15 states have dropped their objections to the new business model.

A congressional committee has heard grievances against the owners of OxyContin maker Purdue Pharma as it considered legislation that would keep them from using a corporate bankruptcy as a shield for personal liability.

Massachusetts Attorney General Maura Healey says she opposes the current plan by Purdue Pharma to settle thousands of lawsuits over the opioid epidemic in part because it would help preserve wealth for members of the Sackler family who own the company.

A group of nearly half the state attorneys general said it was disappointed in the plan Purdue filed late Monday night in federal bankruptcy court and some said they would seek changes. Members of the Sackler family who own Purdue would contribute about $4.3 billion. AdCynthia Munger, of Wayne, Pennsylvania, said Purdue's plan is too focused on providing legal protections for members of the Sackler family. On a Facebook Live video Tuesday, Massachusetts Attorney General Maura Healey, a Democrat, said the payment from Sackler family members was too little. AdIn recent letters to a congressional committee, Sackler family members said those who previously served on Purdue's board of directors had combined net assets of $1.1 billion.

FILE - This Oct. 21, 2020 file photo shows Purdue Pharma headquarters in Stamford, Conn. Two members of the Sackler family have agreed to make a rare public appearance to take questions from a congressional committee that is investigating the role of the company they own, Purdue Pharma, in fueling the nation's opioid epidemic. The company agreed to pay more than $8 billion in forfeitures and penalties, while members of the Sackler family would have to pay $225 million to the government. No family member would be criminally prosecuted under the Justice Department settlement, although the deal leaves open that possibility. A third branch of the family sold their stake in the company before the blockbuster painkiller was developed in the 1990s. In a letter to the Oversight Committee this week, Temple University law professor Jonathan Lipson said the committee should push for family members to contribute more though the bankruptcy process.

The Justice Department says on Wednesday, Purdue Pharma, the company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion. The deal does not release any of the company’s executives or owners — members of the wealthy Sackler family — from criminal liability, and a criminal investigation is ongoing. Family members said they acted “ethically and lawfully,” but some state attorneys general said the agreement fails to hold the Sacklers accountable. Purdue will make a direct payment to the government of $225 million, which is part of a larger $2 billion criminal forfeiture. Until recently, the Sackler name was on museum galleries and educational programs around the world because of gifts from family members.

Copyright 2019 CNN(CNN) - Authorities have identified about $1 billion in wire transfers between the owners of pharmaceutical giant Purdue Pharma, the entities they control and different financial institutions, New York Attorney General Letitia James said Friday. The New York attorney general's office is trying to determine how much money the Sacklers have amassed and where it is. Millions of dollars in wire transfers involving Mortimer D.A. The Sacklers and Purdue Pharma, which makes OxyContin, have fought to limit discovery and subpoena action by the attorney general's office. Some wire transfers continued through last year, the filing saysSackler was involved in 137 wire transfers totaling nearly $20 million, and some of those transfers occurred as recently as 2018, the filing indicates.

Copyright 2019 CNN(CNN) - Purdue Pharma has reached a preliminary proposed settlement with multiple state, local and tribal governments that accuse the company of helping to drive the opioid crisis, officials said. It allows the Sackler family to walk away billionaires and admit no wrongdoing," Shapiro said in a statement obtained by CNN. Sackler family wants a 'global resolution'The Sackler family issued a short statement Wednesday, but did not address the proposed settlement. Attorneys general in Connecticut and Massachusetts told CNN they have not made any settlement agreement with Purdue Pharma at this time. The attorneys general from Tennessee and North Carolina also wrote they expected Purdue Pharma to file for bankruptcy protection "imminently."

The source said the Sacklers would no longer own Purdue Pharma and pay $3 billion out of pocket, plus up to another $1.5 billion dependent on the sale of the company. Purdue Pharma, which manufactures OxyContin, is at the center of the opioid crisis in America. Yesterday, two state attorneys general involved in the talks indicated the negotiations with the Sackler family had broken down, according to a letter provided to CNN by a person with knowledge of the negotiations. The attorneys general from Tennessee and North Carolina also write they expect Purdue Pharma to file for bankruptcy protection "imminently." Previous reports from The New York Times, the Washington Post and NBC news said that the Sackler family would give up ownership of Purdue Pharma and pay at least $3 billion of its own money under terms of the settlement proposal.